Texas Oncology San Antonio Northeast
San Antonio, Texas, United States
Cancer treatment center in San Antonio, Texas
2130 NE Interstate 410 Loop Suite 100, San Antonio, TX 78217
About Texas Oncology San Antonio Northeast
"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
2
Hoffmann-La Roche
2
Seagen Inc.
2
Arcus Biosciences, Inc.
1
Bayer
1
BeiGene
1
Biosplice Therapeutics, Inc.
1
Biotheranostics, Inc.
1
Bristol-Myers Squibb
1
Byondis B.V.
1
Camurus AB
1
Clinical Trials at Texas Oncology San Antonio Northeast
During the past decade, Texas Oncology San Antonio Northeast conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 8 clinical trials were completed, i.e. on
average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
2015-09-01
2021-07-21
Completed
1,504
A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
2016-02-09
2020-06-12
Completed
74
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
2016-01-28
2022-08-11
Completed
612
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
2016-07-01
2021-09-30
Completed
4,310
Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer
2016-06-08
2018-10-03
Completed
123
The Circulating Cell-free Genome Atlas Study
2016-08-04
2024-03-01
Active, not recruiting
15,254
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
2017-02-02
2020-02-28
Terminated
102
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Oncology San Antonio Northeast" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Seagen Inc." with 2 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology San Antonio Northeast"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Texas Oncology San Antonio Northeast
According to Clinical.Site data, the most researched conditions in "Texas Oncology San Antonio Northeast" are
"Advanced Solid Tumor" (2 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Texas Oncology San Antonio Northeast" in a lesser frequency.
Clinical Trials Intervention Types at Texas Oncology San Antonio Northeast
Most popular intervention types in "Texas Oncology San Antonio Northeast" are "Drug" (18 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nivolumab" (3 trials), "Cisplatin" (2 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials) and "(vic-)trastuzumab duocarmazine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Oncology San Antonio Northeast
The vast majority of trials in "Texas Oncology San Antonio Northeast" are
21 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Texas Oncology San Antonio Northeast
Currently, there are NaN active trials in "Texas Oncology San Antonio Northeast".
undefined are not yet recruiting,
7 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Texas Oncology San Antonio Northeast,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Oncology San Antonio Northeast, 4 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".